PURCHASE ORDER
Active75F40126P00150
Department of Health and Human Services › Food and Drug Administration › FDA OFFICE OF ACQ GRANT SVCS
$143K
obligated · signed 2 months ago
CENTRAL NERVOUS SYSTEM (CNS)-3D BRAIN ORGANOIDS NEUROPHARMACOLOGICAL ANALYSIS EO 14398
Performance timeline
Start
Aug 1, 2026
End
Apr 30, 2027
with all options
Loading status
This contract is likely in the recompete window
Ends with all options: Apr 30, 2027
28BIO, INC.
Contract 75F40126P00150
UEI
RT13MNMRHL33
Parent Company
28BIO, INC.
Capabilities & Certifications
Headquarters Location
Congressional District: 01
Current Obligation
$143,021
Base + Exercised Options
$143,021
Total Ceiling Value
$143,021
Contract Type
FIRM FIXED PRICE
NAICS
TESTING LABORATORIES AND SERVICES
PSC
SPECIAL STUDIES/ANALYSIS- MEDICAL/HEALTH
Place of Performance
Congressional District: 01
Awarding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Funding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Solicitation procedures, competition exceptions, labor standards and account totals.